ŒSIV as a model for HIV infection

Dr. Watkins has an extensive background in vaccine research using the Indian rhesus macaque to test vaccine concepts. He has conducted more than 10 vaccine trials in Indian rhesus macaques using a variety of regimens and challenge models. His main interests lie in finding T cell and antibody-based vaccines for several pathogens. He has worked with Brazilian collaborators both at FIOCRUZ and at the University of São Paulo for the last several years and has co-authored multiple publications with them. More recently his laboratory has developed a facility in culturing and measuring viral concentrations and immune responses against flaviviruses as a direct result of the use of recombinant YF17D as a vaccine vector. Dr. Watkins’ extensive experience in testing vaccine approaches in NHP gives him the necessary background to develop vaccine for HTLV-1.